Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06655818
Status:
TERMINATED
Last Update Posted:
None
First Post:
2024-10-22
Brief Title:
Sub-study of Belantamab Mafodotin GSK2857916 as Monotherapy and in Combination With Dostarlimab GSK4057190 in Participants With RRMM
Sponsor:
None
Organization:
None
Organization Data
Organization:
None
Class:
None
Study ID:
None
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
None
Lead Sponsor Class:
None
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None